Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIb trial

Details

Database :

OAIster

Notes :

English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1364938643

Document Type :

Electronic Resource